ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

NCI Projects Only 25% Of R01s Will Be Funded In FY89

November 25, 1988

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

Skipper To Receive Bristol-Myers Award

March 14, 1980

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985